Placebo News and Research

RSS

Study indicates that elderberry juice consumption increases carbohydrate oxidation in obese adults

Researchers evaluated the effects of elderberry juice on indirect calorimetry and insulin sensitivity/ glucose tolerance measures.

27 Apr 2023

Meta-analysis shows phytosterol-fortified foods effectively lower LDL cholesterol levels

Research assesses the effect of foods fortified with phytosterols (PS) on reducing low-density lipoprotein cholesterol (LDL-C) concentrations.

26 Apr 2023

Researchers draw attention to the traps in clinical studies on osteoarthritis

Recruiting osteoarthritis patients with a lot of pain to clinical studies, may give incorrect results if the researcher does account for the natural variation in pain that occurs.

26 Apr 2023

Does oral exposure to cannabidiol (CBD) have toxic implications?

Researchers reviewed the implications of oral exposure to cannabidiol (CBD).

25 Apr 2023

Pain, hope, and science collide as athletes turn to magic mushrooms

The boxer felt broken. Every day, he was waking up in pain. Some days, it was debilitating headaches. Other times, it was his back. Or his fists. His ribs. His nose. On top of that, he had mood swings. Depression. Anxiety.

24 Apr 2023

What are the frequency and risk of adverse events developing in patients with epilepsy who are using CBD?

Researchers evaluated epilepsy patients to evaluate cannabidiol use-related adverse events.

24 Apr 2023

An exploration of the pathophysiological factors and abnormalities of coagulation of long-COVID

Researchers explored the pathophysiological variables and coagulation abnormalities associated with long coronavirus disease (COVID).

21 Apr 2023

Review confirms that cranberry products help prevent urinary tract infections

Review reports that cranberry products containing proanthocyanidins (PACs) can reduce the risk of symptomatic, culture-verified UTIs in women with recurrent UTIs, in children, and in people susceptible to UTIs following interventions.

21 Apr 2023

Study hints at the potential of sleep pills to slow or stop Alzheimer's disease progression

Sleep disturbances can be an early sign of Alzheimer's disease. Many people eventually diagnosed with Alzheimer's start experiencing difficulty falling and staying asleep years before cognitive problems such as memory loss and confusion emerge.

20 Apr 2023

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

20 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

New drug may offer relief for people with difficult-to-treat migraine

The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

20 Apr 2023

Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients

Research reports the results of a randomized, placebo-controlled trial that investigated the effects of combining fluvoxamine and inhaled budesonide for preventing disease progression in high-risk outpatients with COVID-19. The study found that the combination treatment reduced the incidence of severe disease requiring advanced care.

20 Apr 2023

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

In a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.

19 Apr 2023

Surgery may be better option to relieve leg pain and disability in some people with sciatica

Surgery to relieve leg pain and disability in some people with sciatica may be better than other non-surgical treatments, but the benefits are short-lived, lasting only up to 12 months, finds an analysis of the latest evidence published by The BMJ today.

19 Apr 2023

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Researchers evaluated the effectiveness of endogenous metabolic modulator, AXA1125.

19 Apr 2023

Combination treatment could improve stem cell transplantation process for multiple myeloma patients

The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which the patient's own stem cells are harvested and stored while the patient receives intensive chemotherapy to kill the cancer.

17 Apr 2023

Pre- and post-surgical immunotherapy-based treatment significantly improved lung cancer outcomes

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.

17 Apr 2023

Placebo in addition to methadone shown to be feasible treatment for opioid use disorder

There were more than 100,000 reported deaths from opioid overdoses in 2021, according to the Centers for Disease Control and Prevention.

12 Apr 2023

VUMC-led trial demonstrates the inefficacy of two investigational drugs for treating severe COVID-19

Despite the success of vaccines for preventing COVID-19, and of drugs for treating the disease, outcomes for severely ill patients admitted to the hospital remains poor.

11 Apr 2023

Placebo News and Research

Study indicates that elderberry juice consumption increases carbohydrate oxidation in obese adults

Meta-analysis shows phytosterol-fortified foods effectively lower LDL cholesterol levels

Researchers draw attention to the traps in clinical studies on osteoarthritis

Does oral exposure to cannabidiol (CBD) have toxic implications?

Pain, hope, and science collide as athletes turn to magic mushrooms

What are the frequency and risk of adverse events developing in patients with epilepsy who are using CBD?

An exploration of the pathophysiological factors and abnormalities of coagulation of long-COVID

Review confirms that cranberry products help prevent urinary tract infections

Study hints at the potential of sleep pills to slow or stop Alzheimer's disease progression

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

New drug may offer relief for people with difficult-to-treat migraine

Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

Surgery may be better option to relieve leg pain and disability in some people with sciatica

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Combination treatment could improve stem cell transplantation process for multiple myeloma patients

Pre- and post-surgical immunotherapy-based treatment significantly improved lung cancer outcomes

Placebo in addition to methadone shown to be feasible treatment for opioid use disorder

VUMC-led trial demonstrates the inefficacy of two investigational drugs for treating severe COVID-19

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News